Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Materialise NV

Stage 2 · Advancing · week 20

As of Oct 22, 2026, Materialise NV is in Stage 2, the uptrend phase, now in week 20 (since Jun 8, 2026). It closed at $8.53, 2.5% below its 52-week high and above its 200-day average, which is rising.

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. More about the company

$8.53
-0.47% today
$491M · Small cap
Market Neutral — Fading

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 81 in Software - Application · #1 of 242 in Information Technology

Is MTLS early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 16w
S4 25w
S2 17w
S2 20w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 16w → S1 9w → S4 25w → S1 9w → S4 5w → S3 1w → S2 17w → S3 5w → S4 7w → S1 11w → S4 8w → S1 3w → S2 7w → S3 8w → S4 11w → S1 3w → S2 20w current
Total tracked: 165 weeks across 17 stage runs.

MTLS among Software - Application24th of 221 by relative strength

All 221 →
Stocks in Software - Application ranked by relative strength, with stage and one-month change
#StockStageRS1M
1RNGStage 2 · wk 1397+0.2%
2DHXStage 2 · wk 2997+3.5%
3FSLYStage 2 · wk 1197−24.3%
4PUBMStage 2 · wk 2495−1.6%
5FROGStage 2 · wk 2194+1.7%
6MITKStage 3 · wk 593+1.0%
7RSKDStage 2 · wk 1993+24.9%
8OOMAStage 3 · wk 192−10.7%
…24MTLSStage 2 · wk 2081+6.8%
vs 52W High
-2.5%
$4.80 lo$8.75 hi
2.5% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 20
1w13w26w
Week 20, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
34.9%
200 DMA: $6.33 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.62x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+6.8%
3M
+30.2%
6M
+66.9%
YTD
+56.5%
1Y
+38.9%
Scan Membership
Breakout Watch
Latest: 2024-11-07
7 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 20 · Vol 0.62x
2026-10-21S2
Wk 19 · Vol 0.73x
2026-10-20S2
Wk 19 · Vol 0.74x
2026-10-19S2
Wk 19 · Vol 0.96x
2026-10-16S2
Wk 19 · Vol 1.55x
2026-10-15S2
Wk 19 · Vol 2.56x
2026-10-14S2
Wk 18 · Vol 0.99x
2026-10-13S2
Wk 18 · Vol 0.43x
2026-10-12S2
Wk 18 · Vol 0.96x
2026-10-09S2
Wk 18 · Vol 2.22x
2026-10-08S2
Wk 18 · Vol 1.46x
2026-10-07S2
Wk 17 · Vol 0.78x
Moving averages & range
50 DMA
$7.70
200 DMA
$6.33
52W High
$8.75
52W Low
$4.80
5D Low
$8.00
Resistance levels (recent highs)
20d High
$8.75
60d High
$8.75
120d High
$8.75
250d High
$8.75
Next resistance
+2.6%
to 20d High
P/E (TTM)
30.5
Forward 33.0
Earnings Growth (YoY)
+1595.6%
Revenue +8.1%
ROE
+5.2%
Profit margin +4.8%
Dividend Yield
0.00%
P/B 1.7

Materialise NV: quick answers

What stage is Materialise NV in?

As of Oct 22, 2026, Materialise NV (MTLS) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 8, 2026 and is in week 20. What the four stages mean

Is Materialise NV in an uptrend?

Yes. Materialise NV is in a Stage 2 uptrend. It trades 34.9% above its 200-day average, which is rising.

How far is Materialise NV from its 52-week high?

Materialise NV closed at $8.53 on Oct 22, 2026, 2.5% below its 52-week high of $8.75. Its 52-week low is $4.80.

How has Materialise NV performed over the past year?

As of Oct 22, 2026, Materialise NV is up 38.9% over the past year and up 56.5% so far in 2026.

Which sector and industry is Materialise NV in?

Materialise NV is in the Software - Application industry, part of the Information Technology sector.

About this companyInformation Technology· Software - Application

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.